Orca Bio
Mike Knapp is an advisor at Orca Bio. Mike was previously a venture partner at ARCH Venture Partners from September 2012 to May 2017. Before that, they were chairman of Cambrios Technologies from February 2004 to February 2016. Mike was also the CEO of Caliper Life Sciences from January 2002 to December 2003.
Mike Knapp received a BS in Biology from Trinity College-Hartford and a Ph.D. in Medical Microbiology from Stanford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Orca Bio
3 followers
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Their manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling them to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Their talented team is driven by a passion for science and compassion for patients.